Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy. [electronic resource]
Producer: 20020510Description: 119-24 p. digitalISSN:- 0742-3071
- Appetite Depressants -- adverse effects
- Body Mass Index
- Body Weight -- drug effects
- Cholesterol -- blood
- Cyclobutanes -- adverse effects
- Diabetes Mellitus -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Humans
- Hypoglycemic Agents -- adverse effects
- Male
- Middle Aged
- Obesity
- Placebos
- Sulfonylurea Compounds -- adverse effects
- Triglycerides -- blood
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.